Salvianolic Acid B Salvia Miltiorrhiza Root Extract 5% 10% 20% Salvianolic Acid B

• Customization: Available
• Certification: ISO, FDA, HACCP, Halal
• Assay Method: HPLC
• Model NO.: SENTIAN-Salvianolic Acid B
• Product Name: Salvianolic Acid B
• Test Method: HPLC
• Storage: Cool Dry Place
• MOQ: 1kg
• Sample: 10g
• Transport: 1kg/Bag, 25kg/Drum
• Transport Package: Drum, Aluminum Foil Bag
• Specification: 5% 10% 20%
• Trademark: SENTIAN
• Origin: Shanxi, China
• Production Capacity: 50000tons/Year

Product Description

Salvianolic acid B is an organic compound with a molecular formula of C36H30O16 and a relative molecular mass of 718.62. It is a brown-yellow dry powder, and the pure product is an off-white powder or a light yellow powder; it tastes slightly bitter and astringent, and is hygroscopic. It is soluble in water.

   

 

Product Parameters

Salvianolic acid B  SPECIFICATION
Product name	Salvianolic acid B
From	Powder
CAS No.	115939-25-8
Specification	99%
Appearance	brown powder
Package	1KG/Bag,5kg/bag,25kg/drum
Place of Origin	Shaan'Xi,China

 

Salvianolic acid B is formed by the condensation of three molecules of danshensu and one molecule of caffeic acid. It is one of the most studied salvianolic acids and has important pharmacological effects on organs such as the heart, brain, liver, and kidney. This product has the effects of promoting blood circulation and removing blood stasis, promoting blood circulation and activating collaterals. It is mainly used to treat ischemic stroke caused by blood stasis blocking the meridians. Symptoms include numbness of one half of the body, weakness, cramps and pain, or apraxia, crooked mouth and eyes, etc.

Antioxidant
Salvianolic acid B has a strong antioxidant effect. In vitro and in vivo experiments have shown that salvianolic acid B can scavenge oxygen free radicals and inhibit lipid peroxidation. Its effect is stronger than vitamin C, vitamin E, and mannitol. It is one of the strongest known natural products with antioxidant effects. Pharmacological studies have shown that salvianolic acid for injection has a significant antioxidant effect, inhibits platelet aggregation, inhibits thrombosis, and can prolong the survival time of animals under hypoxic conditions. The experiment showed that injection of salvianolic acid (60-15mg/kg) can significantly improve the neurological deficits of rats with cerebral ischemia-reperfusion injury, which is manifested as improved behavioral disorders and significantly reduced cerebral infarction area. There are statistical differences between high and medium doses (60 and 30mg/kg); injection of salvianolic acid significantly improved the neurological damage caused by cerebral ischemia in rats caused by FeCl3 at 1, 2, and 24 hours after administration, which is manifested as improved behavioral disorders and reduced cerebral infarction area; injection of salvianolic acid 40mg/kg significantly inhibited the aggregation reaction of rabbit platelets induced by ADP, arachidonic acid, and collagen, with inhibition rates of 81.5%, 76.7%, and 68.9%, respectively. Injection of salvianolic acid 60 and 30mg/kg significantly inhibited the formation of thrombus in rats; injection of salvianolic acid 60 and 30mg/kg significantly prolonged the survival time of mice under hypoxic conditions.

Protect the heart

Reperfusion of normal blood after acute myocardial ischemia can lead to further damage to the ischemic myocardium, which is manifested by severe cell damage, refractory arrhythmias and obvious cardiac dysfunction in the early stage after reperfusion, which is acute myocardial ischemia-reperfusion injury. During myocardial ischemia-reperfusion, a large number of free radicals are generated, cell membrane lipid peroxidation is enhanced, membrane fluidity and permeability change, leading to abnormal electrophysiological activity, inducing and promoting the occurrence of arrhythmias; myocardial cell lipid peroxidation is enhanced, resulting in an increase in the content of peroxidation product malondialdehyde (MDA) in the myocardial ischemic area, an increase in lactate dehydrogenase (LDH) and creatine phosphokinase (CPK) in the coronary outflow fluid, and a decrease in superoxide dismutase (SOD) in myocardial tissue. Animal experimental studies have shown that salvianolic acid B can reduce the degree of myocardial ischemia in ischemia-reperfusion injury model animals, reduce the scope of myocardial infarction, reduce the overflow of LDH and CPK from the cell body, reduce the content of MDA in ischemic myocardial tissue, increase the activity of SOD, resist the toxic effects of oxygen free radicals on myocardial cells, and protect myocardial cells.

FAQ

Q1. What's the MOQ?
A: MOQ is the minimum sales quantity of the product. Because each product has different prices and different packaging methods, there will be differences. Please consult the relevant professional sales manager for details.

Q2. What's the shipping time?
A: Usually the products we sell have enough stock to deliver the goods in a short

Q3.What transportation methods does our company have?
A: Our company cooperates with DHL and FedEx, as well as airlines and shipping companies. There are also some more efficient transportation methods, such as dedicated transportation lines.

Q4. Can you supply the free sample?
A: Generally, we will provide samples for customer testing to ensure that the quality of our products meets customer requirements.

Q5.Does our company support third-party testing?
A: Our company has long-term cooperation with well-known third-party testing agencies and can provide third-party testing services.